Introduction
In addition to several other factors (e.g., type and virulence of pathogen, general condition of host, immune status), a substantial role is attributed to genetic factors in the development of pediatric sepsis. Several studies have found an association between changes in genes encoding systemic inflammatory response syndrome (SIRS) mediators and sepsis outcome. Some genetic variants can cause structural changes in proteins or changes in the amount of protein produced. Most commonly, this variability only affects a single nucleotide (single-nucleotide polymorphism, SNP). Genetic variants influence the body's susceptibility to the development of sepsis and modify the processes of normal systemic inflammatory response, impairing, or, on the contrary, improving disease outcomes. During SIRS, various causal factors (e.g., trauma, inflammation, infection) trigger the synthesis of proinflammatory, for example, tumor necrosis factor-α (TNF-α), interleukin (IL)-1, IL-6, IL-8, and complement factors C3 and C5, as well as anti-inflammatory cytokines, for example, IL-4 and IL-10. Interestingly, genetic changes in components of the coagulation cascade influence the prognosis of sepsis and may affect molecules involved in pathogen recognition, pro-and anti-inflammatory cytokines, and other effector proteins (►Table 1).
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Abstract
The mortality of childhood sepsis continues to be rather high. When it comes to prevention and adequate therapy, individual differences and genetic alterations are becoming more and more important. These may affect molecules involved in pathogen recognition (e.g., lipopolysaccharide-binding protein, mannose-binding lectin, bactericidal/permeability-increasing protein, Toll-like receptors), signal transduction pathways (e.g., cRel), proinflammatory (e.g., tumor necrosis factor-α, interleukin-1 [IL-1], IL-6, IL-8) as well as anti-inflammatory cytokines (e.g., IL-4, IL-10, IL-1 receptor antagonist), members of the coagulation cascade, and other molecules active in the process of systemic inflammatory response syndrome (e.g., heat shock proteins, complement system). The most common genetic polymorphisms are the so-called single-nucleotide polymorphisms, which entail the change of a single base. Genetic mutations have an impact on susceptibility, severity, and outcome of sepsis. Understanding such mutations may improve treatment efficiency; although there is a considerably limited choice of causal treatments today, they may become available upon future developments in genetic therapy.
Molecules Involved In Pathogen Recognition

Lipopolysaccharide-Binding Protein
Lipopolysaccharide-binding protein (LBP) plays an important role in pathogen recognition and hence in triggering the immune response. First binding to gram-negative bacterial lipopolysaccharide (LPS) to form a complex, LBP is then bound to Toll-like receptor (TLR)-4/CD14/MD2 receptors of macrophages, thereby activating these immunocytes. 1,2 A total of 112 SNPs have been identified in the LBP gene, the most important being rs2232618 (T1412C, Phe436Leu). A study conducted in a Chinese population has found that this SNP increases sepsis and multiple organ failure (MOF) incidence rates in relatively severe posttraumatic patients. 3 Although the study involved an adult population, it is presumable that similar findings would be obtained in pediatric subjects.
Bactericidal/Permeability-Increasing Protein
Bactericidal/permeability-increasing protein (BPI) is primarily found in azurophilic granules of neutrophil granulocytes, but also detectable on the cellular surface and in specific granules of eosinophil granulocytes. 4 It has a role in the defense against gram-negative bacteria by damaging external and internal bacterial membranes and neutralizing LPS, and, on the other hand, playing a part in opsonization. [5] [6] [7] Two frequent polymorphisms have been identified, including the mutation known as BPI Taq (G545C), a so-called silent mutation since causing no change to the encoded amino acid (Val182). 8 It has, however, been found to be associated with sepsis outcome in children, leading to a hypothesis that it may be a marker of other, hitherto unknown functional variants with which it is in a strong linkage disequilibrium. The homozygous GG allele was present in 85% of children with septic shock. No such association is currently known for the other SNP, BPI 216 (A645G, Lys216Glu). 9
NOD2/CARD15
The NOD2 molecule recognizes bacterial particles (e.g., peptidoglycans) and stimulates immune response. 10 Its most important polymorphism is the Leu1007fsinsC mutation, which causes the produced protein to be unable to activate the nuclear factor κB (NF-κB) molecule. 11 This leads to a slowdown of monocytic phagocytosis, which contributes to the development of bacteremia and sepsis.
Toll-like Receptors
TLRs constitute a part of the innate immune system. To date, as many as 11 types have been described. 12 They recognize what is referred to as "pathogen-associated molecular patterns." 13 TLR signal pathways elicit the activation of common transcription factors (NF-κB and mitogen-activated protein kinases [MAPKs] ) and result in the production of cytokines IL-6, IL-10, and IL-12, as well as the costimulatory molecules CD40 and B7. However, although various TLRs bring similar or identical molecules (MyD88, NF-κB) into action during their activation, they can elicit immune responses that are different and unique to a single TLR type.
Toll-like Receptor 1
TLR-1 is found in membranes of macrophages, dendritic cells, eosinophils, basophils, and mast cells, forming a heterodimer with TLR-2. Of the two most common SNPs of the TLR-1 gene, TLR1 -7202A/G (Asn248Ser) , which is found in the 5′ nontranscribed region of the TLR gene, shows a stronger association with clinical outcome than TLR1 1804G/T (Ser602Ile) , which encodes a protein located in the transmembrane domain. 14 TLR1 -7202G is a hypermorphic allele strongly associated with sepsis-related organ damage and mortality in the American population. 15 Increased receptor density on the cellular surface owing to the mutation is thought to be responsible for this effect. In the presence of the TLR1 1804T (602Ile) allele, NF-κB induction is intensified in Staphylococcus aureus infection. 16 With another SNP, TLR1 1805G/T , when the T allele was present in a homozygous form, intensive care unit length of stay significantly increased in septic children whose blood cultures were positive. Compared with G/G homozygous patients, length of stay was also longer in G/T heterozygous cases, which is explained by an increase in neutrophil activation rates when the T allele is present. 17
Toll-like Receptor 2
TLR-2 is the most important member of the receptor family, having a role in the recognition of various bacterial lipoproteins. 18 Several studies have proven that TLR-2 has a fundamental role in antibacterial defense. The TLR-2 gene's best known polymorphism is TLR-2 Arg753Gln, which inhibits tyrosine phosphorylation, dimer formation with TLR6, and the buildup of MyD88, and affects NF-κB activation. 19, 20 Consequently, peptidoglycan-and lipopeptide-triggered intracellular signal transduction and cytokine secretion are compromised, leading to a weakened immune response, which may result in the onset of severe sepsis. 21 Although a study on a smaller group of Asian adults detected no clear association, and no major pediatric studies were completed so far, it is presumed that findings similar to those in adults would be obtained in children. The role in sepsis of another polymorphism, TLR2 Arg677Trp, has not been investigated, but it is clear that this predisposes children to infections caused by S. aureus and other pathogens.
Toll-like Receptor 4
As part of the innate immune system, TLR-4 plays an important role in the defense against gram-negative bacteria, but it also recognizes mycobacterial and fungal proteins, as well as being activated by endogenous ligands. Compounds synthesized due to the signal transduction process triggered by TLR-4 include TNF-α, IL-1β, and interferon-β (IFN-β), among others. There are two polymorphisms known to affect receptor function, Asp299Gly (rs4986790) and Thr399Ile (rs4986791), which cause cytokine synthesis rates to drop, with a consequential increase in susceptibility to gramnegative bacteria. 22 Results concerning a link between these SNPs and sepsis are controversial; haplotype Asp299Gly/ Asp299Gly seems to induce enhanced TNF-α synthesis in response to LPS, thus predisposing to sepsis development, whereas haplotype Asp299Gly/Thr399Ile has no or limited Increases sepsis and MOF incidence rates in relatively severe posttraumatic patient 3 BPI Taq (G545C) The GG allele associates with sepsis outcome in children 9 NOD2/CARD15 Leu1007fsinsC The produced protein unable to activate the NF-κB 11 TLR-1 À7202A/G (Asn248Ser) Strongly associated with sepsis-related organ damage and mortality 15 1805G/T The TT allele increases the intensive care unit length of stay in septic children 17 
TLR-2 Arg753Gln
Inhibits tyrosine phosphorylation, dimer formation with TLR-6, and the buildup of MyD88, and affects NF-κB activation 19, 20 Arg677Trp
Predisposes children to infections caused by Staphylococcus aureus
Cause cytokine synthesis rates to drop, with a consequential increase in susceptibility to gram-negative bacteria 22 haplotype Asp299Gly/ Asp299Gly
Induces enhanced TNF-α synthesis in response to LPS, predisposes to sepsis development [23] [24] [25] rs1927907 Plays a role in the development of S. aureus sepsis 26, 27 CD14 rs2569190 (À159C/T) Leads to increased CD14 levels 32 MBL B,C,D variants Causes the protein's serum levels to drop [35] [36] [37] [38] cRel rs842647 (A61119471G), rs13031237 (G61136129T) rs842647 Ã G increases the risk of MOF in septic patients 40 TNF-α À308G/A TNF2 (A) allele increases TNF-α secretion and mainly affects sepsis onset risks rather than outcomes [43] [44] [45] TNF-β TNFB1, TNFB2 TNFB1 causes elevated serum levels, and hence increased mortality, in septic children 47 IL-1α À889C/T Causes elevated IL-1α expression, which some studies describe as being associated with sepsis 52 IL-1β þ3954C/T Changes splice donor site, leading to the synthesis of fragile, inactive molecules; the T allele increases IL-1β production induced by LPS; the presence of TT alleles carries a reduced risk of sepsis [52] [53] [54] À511G/A Elevates IL-1β levels in response to endotoxins À31C/T Affects transcription factor binding sites, hence transcription activity IL-6 À174G/C The C allele is associated with lower plasma levels; the G allele seems to be protective against sepsis 62, 63 Haplotype variants (À174/1753/2954) Increase mortality or MOF 64 
IL-8 À251T/A (rs4073)
Significantly increases the risk of severe sepsis in newborns; the T allele is protective against sepsis in women
The A allele is protective against sepsis in women 70 rs2227306
The C allele represents an elevated risk of sepsis in men
The T allele has a protective effect against sepsis development
The C allele protects from severe sepsis À1616/À764/ þ 874 haplotype
The CTT haplotype is protective against sepsis; TAC haplotype is associated with susceptibility to sepsis and protects against severe sepsis
Significantly makes worsen late-phase sepsis mortality 76 982C/T Increases early mortality risk in sepsis rs1045411 (2262G/A) The A allele causes far more severe inflammatory response than the GG genotype 
IL-1RA
86 base-pair-long VNTR The A2 allele causes elevated IL-1α, and even higher IL-1β levels; the resulting lower IL-1α:IL-1β ratio leads to more intensified and lengthier inflammatory response and also results in reduced IL-1RA levels in severely septic patients [79] [80] [81] IL-10 À1082(A/G) The A allele is associated with susceptibility to sepsis, whereas the G allele causes enhanced IL-10 production and increases mortality in severe sepsis 83, 84 PC (À1654C/T, À1641A/G) single haplotype
The homozygous GC genotype is associated with significantly lower PC levels increasing the propensity to thrombosis in sepsis; it also worsens outcomes by causing hypotension The homozygous TA genotype has a protective effect on sepsis outcomes The genotype À1641A/A, worsens survival and aggravates systemic inflammation [89] [90] [91] PAI-1 À675 4G/5G insertion/ deletion
The 4G/4G genotype results in elevated plasma levels and activity and increases susceptibility to sepsis and mortality in children with meningococcal infection, as well as raises the incidence of DIC 93, 94 Fibrinogen
The GAA haplotype causes elevated fibrinogen levels owing to the À455A allele, yet it reduces mortality and MOF incidence in sepsis [100] [101] [102] [103] FcyRIIa
R131H
The R131 allotype causes the receptor to bind the IgG2 molecule with a reduced affinity, which results in a slowdown of IgG2-opsonized phagocytosis [110] [111] [112] FcyRIIIa
Val158Phe
Modifies the receptor's affinity to IgG1, IgG2, and IgG4 116, 117 FcyRIIIb switch in four amino acids (Na1/Na2),
Affects the extracellular domain and has a role in protein glycosylation and hence the phagocytosis of particles opsonized by IgG1 and IgG3 [118] [119] [120] CFH Y402H Has a protective effect because inhibition of the alternative pathway becomes muted and has a higher baseline level of activity 131 À496C/T The CC genotype, accompanied by elevated CFH levels, is a factor of increased risk for meningococcal infection 132 
MIF
À173 G/C (rs755622), À794 CATT 5-8 (rs5844572) CATT7/8 is associated with severely complicated malaria, mortality of severely septic patients, and survival in community-acquired pneumonia The low-expression allele (CATT5) has a protective effect against meningococcal infection in children Haplotype À173C/À794CATT7 may help identify patients at increased risk of sepsis mortality [137] [138] [139] 143 HSPA1A rs1008438
The A allele causes hematological impairment 147 rs1043618
The C allele leads to longer intensive care unit treatment periods in H1N1 infection and to a higher incidence of liver failure and MOF in severe trauma cases HSPA1B 1538G/A The A allele causes elevated TNF-α and IL-6 levels 146 1267A > G (rs1061581)
Increases the risk of sepsis in adults with community-acquired pneumonia The AA genotype is clearly associated with sepsis secondary to community-acquired pneumonia The A allele causes hematological impairment 147, 148 HSPA1L
The C allele causes elevated TNF-α and IL-6 levels and is also a significant risk factor for liver failure and MOF 146 HSP70-2 HSP70-2A/G The G allele is associated with lower protein levels and represents an increased risk for sepsis The A allele, a link has been found with TNF-β2, which worsens outcomes in sepsis 149 DDAH2 À449G/C The À449G allele has been shown to result in lower ADMA levels and is more likely to be present in sepsis accompanied by "cold shock" effect on receptor function. [23] [24] [25] Selected studies conclude that rs1927907 polymorphism plays a role in the development of S. aureus sepsis; in this case, the receptor is activated by substances other than LPS, indicating that TLR-4 probably also responds to endogenous ligands. 26, 27 
CD14
The CD14 protein has an important role in the recognition of gram-negative bacteria since it activates the NF-κB pathway by binding to TLR4 as part of the LPS-CD14-MD2 complex. 1 CD14 is found on the surface of monocytes, macrophages, and neutrophil granulocytes in a membrane-linked form, but a soluble form also exists. 28 Elevated CD14 levels pose an increased risk to sepsis and MOF. 29, 30 Many polymorphisms of the gene are known; the most commonly described mutation being rs2569190 (-159 C/T) in the promoter region, leading to increased CD14levels. 31 Its association with sepsis is controversial; although several studies have reported about a link between this polymorphism and sepsis, mainly in the Asian population, but further studies are needed for a clear standpoint in this issue. 32
Mannose-Binding Lectin
Mannose-binding lectin (MBL) is a selectin molecule, which, by binding to mannose and bacterial N-acetyl galactosamine components, activates the complement system through the lectin pathway. 33 There are three known polymorphisms of the MBL-2 gene at the codon 52, 54, and 57 (referred to as variants B, C, and D, respectively, or collectively as O, whereas the wild type denoted as A). The mutations cause an amino acid switch, which interferes with oligomerization, causing the protein's serum levels to drop. Patients with MBL deficiency are more susceptible to sepsis. MBL levels are lower in A/O heterozygosis, whereas circulatory MBL is almost completely absent in O/O homozygous or compound heterozygous cases. 34 Added to these three mutations, there are three major polymorphisms in the promoter region, one of which (-221G/C, also known as Y/X) is a major factor of MBL expression. 35 The three polymorphisms in exon 1 are in linkage disequilibrium with the promoter X/Y polymorphism, with Y being the only variant with a link to each. 36, 37 Polymorphisms Affecting Signal Transduction Pathways cRel Polymorphism
The cRel protein is a subunit of NF-κB. The latter is a protein complex with a central role in the body's response to infections. It is activated through two possible pathways. The canonical pathway involves TLR as well as proinflammatory cytokines (e.g., TNF-α, IL-1) activating the RelA protein, which has proinflammatory effects and activates genes responsible for the cell's survival. 38 The other one is an alternative pathway initiated by LTb, CD40L, BAFF, and RANKL, followed by activation of the RelB/p52 complex, resulting in transcription of genes responsible for lymph organogenesis and B-cell activation. There are two important polymorphisms of the cRel gene: rs842647 and rs13031237;
the former one leading to an A!G substitution at location 61119471 in intron 2, whereas the latter eliciting a G!T switch at location 61136129, intron 4, chromosome 2. It has been shown that the minor allele rs842647 Ã G increases the risk of MOF in septic patients, whereas no association with the severity of septic shock has been found for the allele rs13031237 Ã T. 39 
Proinflammatory Cytokines
Tumor Necrosis Factor-α, Tumor Necrosis Factor Receptor TNF-α is a proinflammatory cytokine involved in the process of SIRS and in initiation of the acute phase reaction. Dominantly produced by activated macrophages, TNF-α can also be a product of CD4þ T-lymphocytes, neutrophils, mast cells, eosinophilic granulocytes, and neurons. Its primary function is immune cell regulation. Bound by either of two receptors, TNFR1 and TNFR2, TNF-α can then activate three pathways: NF-κB, MAPK, and the so-called cell-death pathway. Many SNPs at the TNF/LTA locus have been identified as affecting TNF-α production and being associated with sepsis onset or outcomes. 40 The most commonly known mutation is -308G/ A; notable examples also include the polymorphisms -238G/ A and LTA (TNF-β) þ249 and þ365. 41 The TNF-α -308G/A polymorphism affects the promoter region and causes one TNF1 (G) and one TNF2 (A) allele to be present, the latter leading to increased TNF-α secretion, a condition mainly affecting sepsis onset risks rather than outcomes. [42] [43] [44] As for -238G/A SNP, the -238A allele results in reduced TNF-α levels. 45 The associated TNF-β polymorphism entails a TNFB1 and a TNFB2 allele, with the latter causing elevated serum levels, and hence increased mortality, in septic children. 46 Interleukin-1
Members of the IL-1 family have an important role in inflammatory responses and the pathomechanism of sepsis. The family includes one anti-inflammatory and two proinflammatory (IL-1α and IL-1β) cytokines. [47] [48] [49] The genes are in a cluster on the long arm of chromosome 2 (2q13-21). 50 A total of five SNPs that can be linked to sepsis are known in the IL-1 gene. These include -889C/T in the promoter region of the IL-1α gene, -511G/A and -31C/T in the promoter region of the IL-1β gene, and þ3954C/T in exon 5. 51 þ3954C/T polymorphism causes no amino acid switch, but changes splice donor site, leading to the synthesis of fragile, inactive molecules. 52 The T allele increases IL-1β production induced by LPS. 53 It has also been shown that the presence of TT alleles carries a reduced risk of sepsis; however, this is inconsistent with the observation that elevated IL-1β levels represent greater susceptibility to sepsis. Additional factors are presumed to be in the background of this controversy; further studies into the link between this polymorphism and sepsis are necessary. The IL-1α -889C/T mutation causes elevated IL-1α expression, which some studies describe as being associated with sepsis. Although IL-1β -511G/A elevates IL-1β levels in response to endotoxins, and IL-1β -31C/T affects transcription factor binding sites and hence transcription activity, the link between these SNPs and sepsis remains controversial. 51
Interleukin-6
IL-6 is a proinflammatory cytokine playing an important role in evolvement of the inflammatory response. IL-6 gene polymorphisms may have a role in the development and outcomes of childhood sepsis. 54, 55 It has been reported that in the IL-6 -174G/C mutation, the C allele is associated with lower plasma levels; however, the results are unclear, with some researchers having found such relationship in newborns only, and other studies pointing out that plasma levels of IL-6 variants depend on sex, age, body mass index, and general health. [56] [57] [58] [59] An association with better survival has been detected in GG homozygous cases, and the G allele seems to be protective against sepsis. 60, 61 Moreover, reports also describe a link between haplotype variants (e.g., -174/ 1753/2954) and increased mortality or MOF. 62 The other polymorphism is -572G/C, where the C allele causes a similar deviation in plasma levels compared with the earlier polymorphism. 59 However, the relationship of this variant with sepsis remains unknown.
Interleukin-8
IL-8, also known as neutrophil chemotactic factor, is a chemokine produced by macrophages, epithelial cells, airway smooth muscle cells, and endothelial cells. It has two primary functions including chemotaxis induction in neutrophil and other granulocytes, and having a role in phagocytosis induction and angiogenesis. Elevated IL-8 levels are associated with the development of severe sepsis. 63 Baseline IL-8 level is one of the most important prognostic factors for sepsis outcome. 64 There is a link between IL-8 gene polymorphisms and sepsis onset; SNP IL-8 À251T/A (rs4073) has been described to significantly increase the risk of severe sepsis in newborns. 65 The findings are controversial, with some studies identifying the T allele as causing elevated IL-8 levels and others claiming the same about the A allele even examples of a failure to detect a difference in IL-8 levels for the different alleles that exist. [66] [67] [68] However, the T allele has been found to be protective against sepsis in women. The same was identified in rs1126647 mutation for the A allele. In both cases, a greater incidence of the protective allele was confirmed in women. As for the rs2227306 mutation, the C allele represented an elevated risk of sepsis in men. 69 
Interferon Gamma
INF gamma (IFN-γ) is a cytokine that is an important component of the innate and acquired immunity with a primary role in antiviral defense and an activity against selected bacterial and protozoal species. It is mainly produced by NK and NKT cells, but can also be synthesized by CD4þ Th1 and CD8þ cytotoxic T cells. IFN-γ is an important activator of macrophages and induces major histocompatibility complex II (MHCII) expression. Its importance is rooted in its direct viral replication inhibitory capacity, as well as immunostimulant and immunomodulatory effects. 70 Highlights of IFN-γ gene polymorphisms include four entities with links to immunological pathologies. Two of these, -1616T/C (rs2069705) and -764G/C (rs2069707), are found in the promoter region, with another located in intron 1 (þ874A/T [rs2430561]) and yet another in intron 3 (þ3234C/ T [rs2069718]). Alleles -1616T, -764G, þ874A, and þ3234C have been shown to cause elevated IFN-γ levels compared with their counterpart variants. Reports also indicate that the SNPs þ874 and þ3234 are in a "linkage disequilibrium" with each other. Studies have demonstrated that the -1616T allele has a protective effect against sepsis development and that the þ3234C allele protects from severe sepsis. Research into the haplotypes of -1616, -764, and þ874 found that the CTT haplotype is protective against sepsis, but only minimally protective against the development of severe sepsis, whereas the TAC haplotype is associated with susceptibility to sepsis and protects against severe sepsis. The TAC haplotype comprises three alleles encoding enhanced gene expression and represents the most common combination, with CTT being the rarest. Patients whose IFN-γ expression is enhanced have a greater propensity to develop sepsis but are at a lower risk of severe sepsis, whereas those with lower IFN-γ expression rates are less prone to sepsis. 71
High Mobility Group Box 1
High mobility group box 1 (HMGB1), also known as nuclear nonhistone DNA-binding protein, is a multifunctional cytokine with a role in late-phase inflammatory response. It is mainly produced by macrophages and monocytes in response to LPS through a TNF-α-dependent mechanism, but it is also released by necrotic but not apoptotic cells, which is a way for the body to differentiate between these cells. 72, 73 In addition to its cell-damaging effect, HMGB1 also has a protective function in that it elicits stem cell migration into inflamed areas, promoting regeneration. 74 HMGB1 levels are significantly higher in septic patients, and in mice model, anti-HMGB1 antibodies significantly reduce mortality. 73 The HMGB1 gene has many polymorphisms, two of which have a significance in sepsis; one such mutation is -1377delA, which has been shown to significantly worsen late-phase sepsis mortality. The other polymorphism is 982C/T, which is found in exon 4 and is associated with significantly lower HMGB1 levels than the homozygous 982C/C genotype, thereby increasing early mortality risk in sepsis. 75 Research in Korean children has found that the A allele in rs1045411 (2262G/A) polymorphism causes far more severe inflammatory response than the GG genotype. 76
Anti-Inflammatory Cytokines
Interleukin-1 Receptor Antagonist
As suggested by its name, the IL-1 receptor antagonist binds to the IL-1 receptor to inhibit its function. There is an 86base-pair long VNTR (variable number of tandem repeats) sequence in intron 2 of the IL-1 receptor antagonist (IL-1RA) gene, involving five different alleles (1-5) of different repeat frequencies (4, 2, 5, 3, and 6 repetitions). These are further classified into long (L: 1, 3, 4, 5) and short (2 only) genotypes, with possible combinations including L/L, L/2, and 2/2. 77 The A2 allele causes elevated IL-1α, and even higher IL-1β levels.
The resulting lower IL-1α:IL-1β ratio leads to more intensified and lengthier inflammatory response. 78, 79 This allele also results in reduced IL-1RA levels in severely septic patients. 80 All this indicates that this polymorphism plays an important role in immune response regulation.
Interleukin-10
L-10, also known as "human cytokine synthesis inhibitory factor," is an anti-inflammatory cytokine with a central role in immunoregulation and inflammatory processes. Its functions include down-regulation of cytokines expressed by Th1 cells, moreover that of MHCII antigens and macrophageal costimulant molecules. 81 It also promotes B-cell survival, proliferation, and antibody production. IL-10 inhibits NF-κB activity and has a role in regulation of the JAK-STAT signal pathway. Several IL-10 polymorphisms are known, of which SNP -1082(A/G) in the promoter region has been linked to sepsis. The presence of the A allele is associated with susceptibility to sepsis, whereas that of the G allele causes enhanced IL-10 production and increases mortality in severe sepsis. 82, 83 No such relationship has been found for the other two frequent polymorphisms (-592 and -819). 84
Polymorphisms Affecting the Coagulation System
The coagulation system is activated in sepsis in response to bacterial endotoxins, resulting in enhanced expression of tissue factor in monocytes and endothelial cells, thus activating the extrinsic pathway of the coagulation cascade. However, sepsis essentially leads to complex dysregulation of procoagulant, anticoagulant, and fibrinolytic proteins. The presence of various gene polymorphisms is also important in relation to the outcome of sepsis-related disseminated intravascular coagulation (DIC).
Protein C
Protein C (PC) is a vitamin K dependent zymogenic serine protease synthesized in the liver; once activated and bound to thrombomodulin, it inactivates factors Va and VIIIa in the presence of protein S, PL, and Ca 2þ , thereby blocking any further production of thrombin. It also has anti-inflammatory and antiapoptotic effects. 85 Of the polymorphisms of the PC gene, two located in the gene's 5′ nontranscribed region (-1654C > T, -1641A > G) bear importance. 86, 87 These two polymorphisms form a single haplotype where the homozygous GC genotype is associated with significantly lower PC levels, increasing the propensity to thrombosis in sepsis; it also worsens outcomes by causing hypotension. 88 The homozygous TA genotype has a protective effect on sepsis outcomes because the higher PC levels decrease the incidence of DIC in sepsis, thereby improving survival. 89 The genotype -1641A/A, however, worsens survival and aggravates systemic inflammation. 90 Plasminogen Activator Inhibitor 1
The plasminogen activator inhibitor 1 (PAI-1) molecule is a serine protease inhibitor blocking tissue plasminogen activator (tPA) and urokinase plasminogen activator, the activators of plasminogen and hence fibrinolysis; it also forms a complex with activated PC (APC) to inhibit the latter's function. Based on this behavior, PAI-1 has a procoagulant effect. Several polymorphisms of the PAI-1 gene are known. The most frequently studied polymorphism with an outstanding importance regarding sepsis is the -675 4G/5G insertion/ deletion polymorphism in the promoter region, affecting PAI-1 plasma levels and activity. 91 It has been shown that presence of the 4G/4G genotype results in elevated plasma levels and activity and increases susceptibility to sepsis and mortality in children with meningococcal infection, and also raises the incidence of DIC. 92, 93 Its further consequences include elevated risks of septic shock and MOF in pneumonia-induced sepsis. 94 The significance of this genetic variant lies in the fact that the administration of tPA and APC is a therapeutic option that might improve outcomes. [95] [96] [97] [98] Fibrinogen Fibrinogen, or factor I, is synthesized in the liver. As part of the coagulation cascade, it is converted into fibrin by thrombin. Of the polymorphisms of the fibrinogen-β gene, research into -854G/A, -455G/A, and þ9006G/A revealed that even though the GAA haplotype causes elevated fibrinogen levels owing to the -455A allele, it reduces mortality and MOF incidence in sepsis. [99] [100] [101] [102] This might be explained by the fact that in addition to its role in coagulation, fibrinogen also takes part in the inflammatory process since it is a member of the acute phase proteins; it promotes neutrophil and IL-8 secretion as well as exerts an antiapoptotic effect on endothelial cells and neutrophils. [103] [104] [105] [106] [107] Effector Molecules
Fcy Receptors
Fcy receptors earned their name by binding the Fc region of immunoglobulin G (IgG). They can also be found on many immune and nonimmune cell types. Their task is to stimulate phagocytes or cytotoxic cells, which destroy pathogens or infected host cells by antibody-mediated phagocytosis or through a mechanism referred to as antibody-dependent cell-mediated cytotoxicity. They have three subclasses, FcyRI (FcyrIa), FcyRII (a, b, c), and FcyRIII (a, b), each with a different level of affinity to various IgG antibodies. Several polymorphisms affecting receptor function have been described in these three groups. 108 The most important polymorphism of the FcyRIIa gene results in an arginine-histidine switch at position 131 of the protein (R131H); the R131 allotype causes the receptor to bind the IgG2 molecule with a reduced affinity, which results in a slowdown of IgG2-opsonized phagocytosis. [109] [110] [111] IgG2 is the major antibody subtype in the defense against encapsulated bacteria (e.g., Neisseria meningitidis); this mutation increases the susceptibility for these pathogen. 109, 112, 113 The most significant polymorphism of FcyRIIIa causes a valine-phenylalanine switch at position 158, which modifies the receptor's affinity to IgG1, IgG2, and IgG4. 114, 115 For FcyRIIIb, the polymorphism causes a switch in four amino acids (Na1/Na2), which affects the extracellular domain and has a role in protein glycosylation and hence the phagocytosis of particles opsonized by IgG1 and IgG3. [116] [117] [118] Phagocytosis is more efficient in FcyRIIIb Na1/Na1 homozygosity. Research into the polymorphisms FcyRII H131 and FcyRIIIa Na2 has revealed that both are associated with an increased susceptibility to meningococcal infection. [119] [120] [121] [122] [123] [124] Although the results are controversial, most studies confirm these findings.
Other Molecules
Complement System
The complement system is part of the innate immune system that enhances (complements) the functions of antibodies and phagocytic cells, thus helping to eliminate pathogens and remove damaged cells; on the other hand, it promotes inflammation and directly damages pathogen's membranes. 125 Its activation may occur through three pathways: the classical, lectin, and the alternative pathways. 126 It is important to note that the alternative pathway is constantly activated for antibacterial defense and that it also enhances the other two pathways. 127 The regulatory role of complement factor H (CFH) is extremely important in preventing uncontrolled complement activation and excess damage. CFH levels gradually rise from as early on as the acute phase of inflammation. 128 The effect of complement factor B is the exact opposite, that is, potentiating function of the alternative pathway. The classical and lectin pathways are activated by the C1q protein and MBL, respectively. Gene polymorphisms in components of the complement system affect normal functioning of the system. Such mutations most commonly affect CFH. By inhibiting CFH function, CFH Y402H polymorphism has a protective effect because inhibition of the alternative pathway becomes muted and has a higher baseline level of activity. 129 The CFH -496C/T CC genotype, accompanied by elevated CFH levels, is a factor of increased risk for meningococcal infection. 130 MBL-2 polymorphisms increase the risk of sepsis. In summary, mutations that facilitate rapid and efficient activation of the complement system are protective against sepsis.
Macrophage Migration Inhibitory Factor
"Macrophage migration inhibitory factor" (MIF) is an important regulator of the innate immune system. 131 It plays an important role in acute and chronic inflammatory processes and autoimmune diseases. In response to stimulatory effects of bacterial antigens, white blood cells produce MIF, 132 which binds to CD74 molecules on the surfaces of other immunocytes, triggering the acute immune response. MIF is constantly expressed by macrophages and monocytes and has autocrine, paracrine, and endocrine effects when secreted into the extracellular space. Interestingly, glucocorticoids also induce MIF secretion, which, in turn, counters their anti-inflammatory effect. For note, the frontal hypophysis also produces MIF in response to trauma. 133 There are four known polymorphisms to the MIF gene. The SNPs þ254
(þ254 Ã T/C) and þ656 (þ656 Ã C/G) are in the introns but bear no functional significance. 134 This is in contrast with the other two polymorphisms situated in the promoter region. One of them is an SNP (À173 G/C; rs755622), whereas the other is a microsatellite (À794 CATT [5] [6] [7] [8] ; rs5844572). The most frequent allele in the Caucasian population is CATT6. Genotypes are classified into a so-called low-expression group with lower MIF levels (5-CATT allele or -173GG) and a high-expression group (7-CATT or the -173C alleles). The -173G allele is much more prevalent than the C allele. Infectious disease studies have shown that high-expression MIF alleles (CATT7/8) or haplotypes are associated with severely complicated malaria, mortality of severely septic patients, and survival in community-acquired pneumonia. 135, 136 Also, the low-expression allele (CATT5) has a protective effect against meningococcal infection in children. 137 This suggests that the effects of MIF polymorphisms are modified by age, infection site, pathogen type, and other confounding factors (e.g., selection bias). [138] [139] [140] Another study has reported that although the haplotype -173C /-794CATT7 is not useful as a susceptibility marker for sepsis, it may still help identify patients at increased risk of sepsis mortality. 141 The practical significance of research into MIF polymorphisms lies in an ongoing phase 1/2a study for the efficacy assessment of an anti-MIF monoclonal antibody (BAX/imalumab) in patients with metastatic colorectal carcinoma or ovarian cancer with malignant ascites. 134 Potential future use of the antibody might even include the treatment of severe sepsis.
Heat Shock Proteins
Heat shock proteins are members of a family of proteins produced in response to cells being exposed to stressful conditions. Some members of this family have "chaperone" function; they stabilize newly synthesized proteins, facilitate correct folding, and help damaged proteins to refold. 142 As for the immune system, the most important heat shock protein is HSP70 located in the cell membrane because it plays a role in antigen binding and presentation to immunocytes. The gene encoding HSP70 is found in the HLA locus on the short arm of chromosome 6. There are many known polymorphisms to the HSP70 gene, of which HSPA1A, HSPA1B, and HSPA1L have significance in relation to sepsis. Polymorphisms of the HSPA1B and HSPA1L genes modify the levels of selected cytokines and thus the process of SIRS. For example, the A allele in HSPA1B 1538G/A, as well as the C allele in HSPA1L 2437 T > C, causes elevated TNF-α and IL-6 levels, and the C allele is also a significant risk factor for liver failure and MOF. 143 It has been reported that 1267A > G mutation in the HSPA1B gene increases the risk of sepsis in adults with community-acquired pneumonia. 144, 145 The A allele of rs1061581 and the rs1008438 mutation both cause hematological impairment, whereas the C allele of rs1043618 leads to longer intensive care unit treatment periods in H1N1 infection and to a higher incidence of liver failure and MOF in severe trauma cases. 144 Another study points out that AA (rs1061581) genotype of the HSPA1B gene is clearly associated with sepsis secondary to community-acquired pneumonia. 145 This polymorphism is in a strong "linkage disequilibrium" with that of the promoter regions of HSPA1A and HSPA1B. 146 Investigations into the HSP70-2A/G polymorphism found that the G allele is associated with lower protein levels and represents an increased risk for sepsis. For the A allele, a link has been found with TNF-b2, which worsens outcomes in sepsis. 146 
Dimethylarginine Dimethylaminohydrolase
Dimethylarginine dimethylaminohydrolase (DDAH) metabolizes the asymmetric dimethylarginine (ADMA) molecule, which is an inhibitor of inducible nitric oxide synthase. 147 The effects of NO include vasodilation, intense inflammatory response, and reduced thrombocyte and leukocyte adhesion, and it also has a free radical scavenger function. ADMA is synthesized from L-arginine by protein arginine methyltransferase. There is an association between ADMA levels and sepsis. 148 The DDAH2 gene has two relatively known polymorphisms: -871 6 g/7 g insertion/deletion and the SNP -449G/C. [148] [149] [150] [151] The latter has a significance in sepsis since the -449G allele has been shown to result in lower ADMA levels and is more likely to be present in sepsis accompanied by "cold shock." 152
Discussion
Changes to genes of sepsis mediators have an important role in the susceptibility to the severity and outcome of sepsis. Currently available choices in gene therapy are limited; nevertheless, options do exist and include antibody treatment against abnormally high levels of mediators produced by a mutation (e.g., monoclonal antibodies used against MIF), or potential administration of tPA or APC in genetic alterations of PAI-1. With the advance of molecular genetic methods, genetic testing, even screening, of patient groups at high risk of sepsis, for example, children with chronic diseases (leukemia etc.), may become reality in the future. This would offer a way to reduce the risk of sepsis onset by gene therapy in selected patients carrying mutations; in the interim until such therapy is available, stricter observation and more aggressive sepsis therapy could improve outcomes in these patients. This, however, necessitates further research to clarify in detail the sepsis-related roles of each polymorphism.
